Brind.

Philippe Martin was appointed Chief R&D Officer at Viatris in June 2025.

1 report, 0 independent Updated Jun 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Philippe Martin Mylan

Keep exploring

The entities involved

Philippe Martin
remote sensing (land use) researcher (ORCID 0000-0001-5551-8016)

Nothing else this week.
Mylan
former pharmaceutical company
- Mylan and Zymeworks are involved in a deal aimed at bolstering Zymeworks’ commercial portfolio, related to COPD therapy.Mon 11:01
- Zymeworks is leveraging Irish tax attributes as part of its deal with Mylan.Mon 11:01

Coverage

Newest first; wire copies grouped

Jun 26Unknown outlet